Replies to post #438004 on Amarin Corp Plc (AMRN)

[Whalatane]

Which is why this trial that you and North found is important https://clinicaltrials.gov/study/NCT06637657?tab=table

Real world use , no placebo , hard outcomes .
Vazkepa will be immediately added to half this population of acute coronary patients as per REDUCE IT guidelines .
The other half will get Vazkepa as part of SOC at MD's discretion and timing
Large trial ...so should have stat sig results ( well powered )
36 mths ...definitely enough time to see event lines diverge
JMO
Kiwi